Cargando…
Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
Ebola virus (EBOV) causes severe viral hemorrhagic fever in humans and non-human primates, with a case fatality rate of up to 88% in human outbreaks. Over the past 3 years, monoclonal antibody (mAb) cocktails have demonstrated high efficacy as treatments against EBOV infection. One such cocktail is...
Autores principales: | Audet, Jonathan, Wong, Gary, Wang, Han, Lu, Guangwen, Gao, George F., Kobinger, Gary, Qiu, Xiangguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381473/ https://www.ncbi.nlm.nih.gov/pubmed/25375093 http://dx.doi.org/10.1038/srep06881 |
Ejemplares similares
-
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
por: Qiu, Xiangguo, et al.
Publicado: (2013) -
Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012) -
Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
por: Wong, Gary, et al.
Publicado: (2014) -
Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice
por: Wong, Gary, et al.
Publicado: (2015) -
Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2021)